Matthew Ros - Net Worth and Insider Trading
Matthew Ros Net Worth
The estimated net worth of Matthew Ros is at least $122,286 dollars as of 2024-11-13. Matthew Ros is the See Remarks of Epizyme Inc and owns about 83,188 shares of Epizyme Inc (EPZM) stock worth over $122,286. Details can be seen in Matthew Ros's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Ros has not made any transactions after 2021-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Ros
Matthew Ros Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Ros owns 2 companies in total, including Cogent Biosciences Inc (COGT) , and Epizyme Inc (EPZM) .
Click here to see the complete history of Matthew Ros’s form 4 insider trades.
Insider Ownership Summary of Matthew Ros
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COGT | Cogent Biosciences Inc | 2021-01-04 | director |
| EPZM | Epizyme Inc | 2021-02-04 | Chief Operating Officer |
Matthew Ros Latest Holdings Summary
Matthew Ros currently owns a total of 1 stock. Matthew Ros owns 83,188 shares of Epizyme Inc (EPZM) as of February 4, 2021, with a value of $122,286.
Latest Holdings of Matthew Ros
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EPZM | Epizyme Inc | 2021-02-04 | 83,188 | 1.47 | 122,286 |
Holding Weightings of Matthew Ros
Matthew Ros Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Ros has made a total of 6 transactions in Epizyme Inc (EPZM) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Epizyme Inc is the sale of 894 shares on February 4, 2021, which brought Matthew Ros around $10,022.
Insider Trading History of Matthew Ros
- 1
Matthew Ros Trading Performance
Matthew Ros Ownership Network
Ownership Network List of Matthew Ros
Ownership Network Relation of Matthew Ros
Matthew Ros Owned Company Details
What does Cogent Biosciences Inc do?
Who are the key executives at Cogent Biosciences Inc?
Matthew Ros is the director of Cogent Biosciences Inc. Other key executives at Cogent Biosciences Inc include 10 percent owner & other: See Remarks Fairmount Funds Management Llc , Chief Legal Officer Evan Kearns , and Chief Financial Officer John L. Green .
Cogent Biosciences Inc (COGT) Insider Trades Summary
Over the past 18 months, Matthew Ros made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,
In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.
Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cogent Biosciences Inc Insider Transactions
Matthew Ros Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Ros. You might contact Matthew Ros via mailing address: C/o Epizyme, Inc., 400 Technology Square, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
